Literature DB >> 27058406

Native Electrocardiographic QRS Duration after Cardiac Resynchronization Therapy: The Impact on Clinical Outcomes and Prognosis.

Oguz Karaca1, Beytullah Cakal2, Mehmet Onur Omaygenc2, Haci Murat Gunes2, Sinem Deniz Cakal2, Filiz Kizilirmak2, Tayyar Gokdeniz2, Irfan Barutcu2, Bilal Boztosun2, Fethi Kilicaslan3.   

Abstract

BACKGROUND: We investigated whether reversed electrical remodeling (RER), defined as narrowing of the native electrocardiographic QRS duration after cardiac resynchronization therapy (CRT), might predict prognosis and improvement in echocardiographic outcomes. METHODS AND
RESULTS: A total of 110 CRT recipients were retrospectively analyzed for the end points of death and hospitalization during 18 ± 3 months. Native QRS durations were recorded at baseline and 6 months after CRT (when pacing was switched off to obtain an electrocardiogram) to determine RER. CRT response and mitral regurgitation (MR) improvement were defined as ≥15% reduction in left ventricular end-systolic volume and absolute reduction in regurgitant volume (RegV) at 6 months, respectively. Overall, 48 patients (44%) had RER, which was associated with functional improvement (77% vs 34%; P < .001) and CRT response (81% vs 52%; P < .001) compared with those without RER. The change in the intrinsic QRS duration correlated with the reduction in RegV (r = 0.51; P < .001) and in tenting area (r = 0.34; P < .001). RER was a predictor of MR improvement (P = .023), survival (P = .043), and event-free survival (P = .028) according to multivariate analyses.
CONCLUSIONS: Narrowing of the intrinsic QRS duration is associated with functional and echocardiographic CRT response, reduction in MR, and favorable prognosis after CRT.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Native QRS duration; cardiac resynchronization therapy response; mitral regurgitation; prognosis; reversed electrical remodeling

Mesh:

Year:  2016        PMID: 27058406     DOI: 10.1016/j.cardfail.2016.04.001

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  4 in total

1.  Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies.

Authors:  George Bazoukis; Katerina K Naka; Alawi Alsheikh-Ali; Gary Tse; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Cynthia Yeung; Michael Efremidis; Konstantinos Tsioufis; Adrian Baranchuk; Stavros Stavrakis
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

2.  Improvement in left ventricular intrinsic dyssynchrony with cardiac resynchronization therapy.

Authors:  Serdar Bozyel; Ayşen Ağaçdiken Ağır; Tayfun Şahin; Umut Çelikyurt; Müjdat Aktaş; Onur Argan; İrem Yılmaz; Kurtuluş Karaüzüm; Emir Derviş; Ahmet Vural; Dilek Ural
Journal:  Anatol J Cardiol       Date:  2017-03-03       Impact factor: 1.596

Review 3.  The Role of Cardiac Resynchronization Therapy for the Management of Functional Mitral Regurgitation.

Authors:  Eleonora Russo; Giulio Russo; Mauro Cassese; Maurizio Braccio; Massimo Carella; Paolo Compagnucci; Antonio Dello Russo; Michela Casella
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

4.  A Patient with Left Bundle Branch Block and Persistent Atrial Fibrillation Treated with Cardiac Catheter Ablation and Pharmacologic Cardiac Resynchronization Therapy without the Use of an Implantable Cardiac Device.

Authors:  Hideyuki Hasebe
Journal:  Am J Case Rep       Date:  2018-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.